May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Adjuvant Decorin Therapy for Wound Healing Suppression after Filtrating Glaucoma Surgery
Author Affiliations & Notes
  • P. Szurman
    University Eye Hospital Tubingen, Tubingen, Germany
  • S. Grisanti
    University Eye Hospital Tubingen, Tubingen, Germany
  • F. Ziemssen
    University Eye Hospital Tubingen, Tubingen, Germany
  • M. Warga
    University Eye Hospital Tubingen, Tubingen, Germany
  • K.U. Bartz-Schmidt
    University Eye Hospital Tubingen, Tubingen, Germany
  • Footnotes
    Commercial Relationships  P. Szurman, None; S. Grisanti, None; F. Ziemssen, None; M. Warga, None; K.U. Bartz-Schmidt, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1202. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      P. Szurman, S. Grisanti, F. Ziemssen, M. Warga, K.U. Bartz-Schmidt; Adjuvant Decorin Therapy for Wound Healing Suppression after Filtrating Glaucoma Surgery . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1202.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the antifibrotic capacity of subconjunctival Decorin as adjuvant therapy in trabeculectomy in rabbit eyes. Methods: Trabeculectomy was performed in 15 rabbit eyes divided into three subgroups of 5 eyes: trabeculectomy (1) without adjuvant therapy, (2) with 0.04 mg Decorin, (3) with 0.1 mg Decorin. In the Decorin groups subconjunctival injection was applied 15 min before operation and the four successive postoperative days. Operative procedure comprised a limbus based conjunctival approach, preparation of a 2.5 x 2.5 mm scleral flap, trepanation with a 1.5 mm trephine and subsequent iridectomy. Postoperatively, intraocular pressure was monitored by indentation tonometry in both eyes. After 2 weeks, the eyes were enucleated and processed for histological examination. Clinical success was defined as intraocular pressure ratio smaller than 0.8 compared to the non-operated eye. Results: In the control group intraocular pressure exceeded a ratio of 0.8 after 7 days postoperatively, while the Decorin groups maintained a pressure ratio less than 0.8 during the follow up time of 2 weeks. Eyes with 0.04 mg Decorin disclosed a mean ratio of 0.75 ± 0.09, eyes with 0.1 mg Decorin showed a more pronounced effect with 0.58 ± 0.11. Histology in control eyes disclosed a marked tenon proliferation with subconjunctival deposition of extracellular matrix and scleral flap scarring. Eyes with adjuvant Decorin showed a significantly reduced fibrosis and deposition of collagen material being more distinctive in the 0.1 mg Decorin group. Conclusions: Decorin in the applied concentrations might be an effective antifibrotic adjuvant in trabeculectomy, showing significant reduction of extracellular matrix deposition and subsequently a beneficial effect on postoperative scarring and intraocular pressure reduction.

Keywords: wound healing • extracellular matrix • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×